• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Br J Gen Pract . Clinical presentation and disease course in patients with flu-like illness: does microbiological aetiology matter?

tetano

Editor, Senior Moderator
Br J Gen Pract


. 2021 Dec 13;BJGP.2021.0344.
doi: 10.3399/BJGP.2021.0344. Online ahead of print.
Clinical presentation and disease course in patients with flu-like illness: does microbiological aetiology matter?


Theo Verheij[SUP] 1 [/SUP], Daniela Cianci[SUP] 2 [/SUP], Alike van der Velden[SUP] 2 [/SUP], Christopher C Butler[SUP] 3 [/SUP], Emily Bongard[SUP] 3 [/SUP], Samuel Coenen[SUP] 4 [/SUP], Annelies Colliers[SUP] 4 [/SUP], Nick Francis[SUP] 5 [/SUP], Paul Little[SUP] 5 [/SUP], Maciek Godycki-Cwirko[SUP] 6 [/SUP], Carl Llor[SUP] 7 [/SUP], Slawomir Chlabicz[SUP] 8 [/SUP], Christos Lionis[SUP] 9 [/SUP], Pär-Daniel Sundvall[SUP] 10 [/SUP], Lars Bjerrum[SUP] 7 [/SUP], An De Sutter[SUP] 11 [/SUP], Rune Aabenhus[SUP] 7 [/SUP], Nicolay Jonassen Harbin[SUP] 12 [/SUP], Morten Lindbaek[SUP] 12 [/SUP], Dominik Glinz[SUP] 13 [/SUP], Heiner Bucher[SUP] 13 [/SUP], Bernadett Kovacs[SUP] 14 [/SUP], Bohumil Seifert[SUP] 15 [/SUP], Pia Touboul Lundgren[SUP] 16 [/SUP], Muireann de Paor[SUP] 17 [/SUP], Ruta Radzeviciene JUrgute[SUP] 18 [/SUP], Veerle Matheeussen[SUP] 19 [/SUP], Herman Goossens[SUP] 19 [/SUP], Margareta Ieven[SUP] 19 [/SUP]



Affiliations

Abstract

Background: There is little evidence about the relation between aetiology, illness severity and clinical course of respiratory tract infections (RTI) in primary care. Understanding these associations would aid to develop effective management strategies for these infections.
Aim: To investigate whether the clinical presentation and illness course differ between RTI in whom a viral pathogen was detected and those in whom a potential bacterial pathogen was found.
Design and setting: Post hoc analysis of data from a pragmatic randomised trial on the effects of oseltamivir in patients with influenza-like illness (ILI) in primary care (n=3266) in 15 European countries.
Methods: Patient characteristics, signs and symptoms were registered at baseline. Naso-pharyngeal (adults) or nasal and pharyngeal (children) swabs were taken for PCR analysis. Patients were followed up until 28 days after inclusion. Regression models and Kaplan-Meier curves were used to analyse the relation between aetiology, clinical presentation at baseline and course of disease including complications.
Results: Except for a less prominent congested nose (OR 0.55, CI 0.35 - 0.86) and acute cough (OR 0.52, CI 0.27 - 0.65) in ILI patients in whom a possible bacterial pathogen was isolated, there were no clear clinical differences in presentations between those with a possible bacterial aetiology than in those with a viral one. Also the course of disease and complications were not related to aetiology.
Conclusion: Given the currently available microbiological tests and antimicrobial treatments, and outside pandemics like COVID-19, microbiological testing in primary care patients with ILI seems to have limited value.

Keywords: Cancer; Cardiovascular disease; Clinical (general); Clinical (physical); Consultation skills; Continuity of care; Gastroenterology.
 
Back
Top Bottom